Nano-Bowls for Lung Cancer Treatment
Author Information
Author(s): Ngema Lindokuhle M., Acter Shahinur, Adeyemi Samson A., Marimuthu Thashree, Govender Mershen, Ngwa Wilfred, Choonara Yahya E.
Primary Institution: Wits Advanced Drug Delivery Platform, University of the Witwatersrand
Hypothesis
Can mesoporous polydopamine nano-bowls effectively deliver paclitaxel to suppress lung cancer cell proliferation?
Conclusion
The study demonstrates that mesoporous polydopamine nano-bowls can effectively deliver paclitaxel, significantly reducing lung cancer cell proliferation.
Supporting Evidence
- The nano-bowls achieved a 95.7% entrapment efficiency for paclitaxel.
- 85.1% of paclitaxel was released at acidic pH, simulating the tumor microenvironment.
- Cell viability was reduced to 14.0% and 9.3% at 48 and 72 hours, respectively, with the highest concentration of the nano-bowls.
Takeaway
Researchers created tiny bowl-shaped particles that can carry a cancer drug and release it in a way that helps fight lung cancer better.
Methodology
The study involved fabricating mesoporous polydopamine nano-bowls and testing their ability to entrap and release paclitaxel in vitro.
Limitations
The study primarily focuses on in vitro results, and further in vivo studies are needed to confirm efficacy.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website